These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28232654)

  • 1. [Advances in genome editing technologies for treating muscular dystrophy.].
    Makita Y; Hozumi H; Hotta A
    Clin Calcium; 2017; 27(3):391-399. PubMed ID: 28232654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome Editing Gene Therapy for Duchenne Muscular Dystrophy.
    Hotta A
    J Neuromuscul Dis; 2015 Sep; 2(4):343-355. PubMed ID: 27858753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Based Therapeutic Gene Editing for Duchenne Muscular Dystrophy: Advances, Challenges and Perspectives.
    Chen G; Wei T; Yang H; Li G; Li H
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of viral vectors as vehicles for DMD gene editing.
    Maggio I; Chen X; Gonçalves MA
    Genome Med; 2016 May; 8(1):59. PubMed ID: 27215286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell and gene therapy in Duchenne muscular dystrophy.
    Morgan JE
    Hum Gene Ther; 1994 Feb; 5(2):165-73. PubMed ID: 7514447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
    Matsumura K; Campbell KP
    Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo gene editing of the dystrophin gene in muscle stem cells mediated by peptide nucleic acid single stranded oligodeoxynucleotides induces stable expression of dystrophin in a mouse model for Duchenne muscular dystrophy.
    Nik-Ahd F; Bertoni C
    Stem Cells; 2014 Jul; 32(7):1817-30. PubMed ID: 24753122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duchenne muscular dystrophy: genome editing gives new hope for treatment.
    Crispi V; Matsakas A
    Postgrad Med J; 2018 May; 94(1111):296-304. PubMed ID: 29386334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy prospects for Duchenne muscular dystrophy.
    Clemens PR; Caskey CT
    Eur Neurol; 1994; 34(4):181-5. PubMed ID: 8082675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward the correction of muscular dystrophy by gene editing.
    Olson EN
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34074727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular genetics of Duchenne/Becker muscular dystrophy].
    Saito K; Ikeya K; Kondo E; Yamauchi A; Komine S; Fukuyama Y
    Nihon Rinsho; 1993 Sep; 51(9):2420-7. PubMed ID: 8411723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for muscular dystrophy - a review of promising progress.
    Gregorevic P; Chamberlain JS
    Expert Opin Biol Ther; 2003 Aug; 3(5):803-14. PubMed ID: 12880380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic therapeutic approaches for Duchenne muscular dystrophy.
    Foster H; Popplewell L; Dickson G
    Hum Gene Ther; 2012 Jul; 23(7):676-87. PubMed ID: 22647146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration.
    Bertoni C; Jarrahian S; Wheeler TM; Li Y; Olivares EC; Calos MP; Rando TA
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):419-24. PubMed ID: 16387861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress towards gene therapy for Duchenne muscular dystrophy.
    Hauser MA; Chamberlain JS
    J Endocrinol; 1996 Jun; 149(3):373-8. PubMed ID: 8691095
    [No Abstract]   [Full Text] [Related]  

  • 16. A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells.
    Young CS; Hicks MR; Ermolova NV; Nakano H; Jan M; Younesi S; Karumbayaram S; Kumagai-Cresse C; Wang D; Zack JA; Kohn DB; Nakano A; Nelson SF; Miceli MC; Spencer MJ; Pyle AD
    Cell Stem Cell; 2016 Apr; 18(4):533-40. PubMed ID: 26877224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular pathology of Duchenne and Becker muscular dystrophy].
    Gilgenkrantz H; Chelly J; Récan D; Chafey P; Kaplan JC
    C R Seances Soc Biol Fil; 1992; 186(4):349-53. PubMed ID: 1301222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
    Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
    Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Duchenne muscular dystrophy].
    Ishiura S; Sugita H
    No To Shinkei; 1991 May; 43(5):405-9. PubMed ID: 1910927
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular therapy of muscular dystrophy].
    Takeda S
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1267-9. PubMed ID: 11464475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.